Company Profile
Yili Chuanning Biotechnology provides the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and globally. It offers antibiotic intermediates comprising erythromycin thiofluorate. Its portfolio also includes cephalosporin intermediates consisting of 7-aminocephalosporanic acid (7-ACA), 7-amino-3-deacetoxycephalosporinic acid (7-ADCA), and D-7ACA, penicillin intermediates, such as 6-aminopenicillanic acid (6-APA) and penicillin G potassium salt, ursodeoxycholic acid, coenzyme Q10 mycelia, and products
Synthetic biology products, including bisabolol, 5-hydroxytryptophan, ergothioneine, ectoine, inositol, squalane, polyhydroxyalkanoate (PHA), and phytosphingosine. Additionally, it engages in trading, crop cultivation, detection, technical consultation, and asset investment activities. Yili Chuanning Biotechnology Co.,Ltd. The company was incorporated in 2010 and is based in Yining, China. operates as a subsidiary of Sichuan Kelun Pharmaceutical Co., Ltd.